Stockreport

InnovAge Holding Corp (INNV) Reports Fiscal Q2 2024 Earnings: Key Financial Metrics Revealed [Yahoo! Finance]

InnovAge Holding Corp.  (INNV) 
NASDAQ:AMEX Investor Relations: innovuspharma.com
PDF Adjusted EBITDA : Improved to $7.8 million in Q2 2024, a significant rise from a loss of $1.9 million in Q2 2023. Center-level Contribution Margin : Increased by 48.9 [Read more]